CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, ...

U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for ...

Lower extremity orthopedic disorders, particularly degenerative diseases and related deformities, are a leading cause of pain and disability worldwide, ...

Zimmer Biomet saw a strong first quarter, and U.S. growth in particular was bolstered by the hip franchise, CEO Ivan Tornos said in an earnings call. “Our U.S. hip franchise grew 5% in the quarter as ...

Zimmer Biomet is off to a strong start to 2026 but stopped short of raising guidance for the year. Here's what the CEO had to ...

Cheesy memes about people being excited for their "knee surgery tomorrow" began making the rounds in the early 2020s. Here's ...

Zimmer Biomet (NYSE:ZBH) executives said the company began fiscal 2026 with organic constant-currency revenue at the high end ...

Partial meniscectomy does not improve patient symptoms or function, reveals a 10-year follow-up of the FIDELITY, a ...

Q1 2026 earnings call highlights: sales, raised EPS/FCF guidance, tariffs, knee trends and Monogram timing—read the key takeaways.

Zimmer Biomet (ZBH) stock slides despite better than expected Q1 2026 financialsas the company annouces the departure of its ...

Zimmer Biomet on Tuesday raised its 2026 adjusted profit forecast after reporting better-than-expected quarterly results, ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026. The Company reported first quarter net sales of $2.087 billion, an increase of 9 ...